Thomas Wilder
CIK 1491299 · last filed 2026-02-18
Thomas Wilder is a corporate insider who has filed 54 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for PEN, was dated Feb 18, 2026. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.62M
2
54
-$1.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEN | Director | 5,095 | $318.71 | $1.62M | -$979.7K | 35 | 2026-02-18 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 27,864 | — | — | -$854.7K | 18 | 2019-10-01 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-18 | PEN | Grant (A) | +589 | $0 | EDGAR |
| 2026-01-06 | PEN | Sell (S) | −186 | -$57.8K | EDGAR |
| 2025-10-03 | PEN | Sell (S) | −186 | -$47.2K | EDGAR |
| 2025-08-13 | PEN | Sell (S) | −372 | -$89.3K | EDGAR |
| 2025-04-04 | PEN | Sell (S) | −360 | -$96.1K | EDGAR |
| 2025-04-02 | PEN | Sell (S) | −360 | -$95.2K | EDGAR |
| 2025-02-19 | PEN | Grant (A) | +744 | $0 | EDGAR |
| 2024-02-21 | PEN | Grant (A) | +665 | $0 | EDGAR |
| 2023-08-09 | PEN | Sell (S) | −340 | -$86.2K | EDGAR |
| 2023-02-22 | PEN | Grant (A) | +680 | $0 | EDGAR |